A study in this month's issue of the Annals of Internal Medicine summarizes published literature on the efficacy and safety of oral direct-acting antivirals for treatment of persons with chronic HCV infection.
The most recent issue of the Alimentary Pharmacology & Therapeutics quantified the cumulative incidence of HCC among a representative population of people with cirrhosis of the liver of varying etiology.
April's issue of Gut validated the IBD-DI in an independent patient cohort, to develop an index-specific scoring system, and to describe the disability status of a well-defined population-based cohort of French patients with IBD.
A genome-wide association study reported in May's issue of Gastroenterology identifies TLL1 variant associated with development of hepatocellular carcinoma after eradication of Hepatitis C virus infection.
Published ahead of print, a study in the Alimentary Pharmacology & Therapeutics reviews the diverse prognostic models that have been proposed to refine the prognostic prediction of patients with hepatocellular carcinoma undergoing trans-arterial chemoembolization.